Phase 1 completion is not happening in the US, it’s in Australia and AGN is a direct comparison to NYR
R&D rebate gets announced this month and tops them up around 2 million dollars in the bank. They will have 6-7 million dollars in September leading into phase 1. They are fully funded to phase 2 preparations and FDA submission for phase 2.
NYR only needs to prove it’s safe. AGN has done all the heavy lifting in the mechanism of action and efficacy. If you did any research AGN and NYR work by reducing calcium influx in the cell. AGN has already proven up that NYR works as their mechanism of action targets the same receptors
Ann: Brain Injury Program GLP Studies Further Update, page-15
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.001(1.00%) |
Mkt cap ! $18.03M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $28.89K | 289.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73984 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 127592 | 3 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |